CCK-8-RELATED C-TERMINAL TETRAPEPTIDES - AFFINITIES FOR CENTRAL CCKB AND PERIPHERAL CCKA RECEPTORS

被引:16
作者
HARHAMMER, R
SCHAFER, U
HENKLEIN, P
OTT, T
REPKE, H
机构
[1] Institute of Pharmacology and Toxicology, Humboldt University of Berlin, D-1040 Berlin
关键词
CCK-8 (CHOLECYSTOKININ OCTAPEPTIDE); CCKB RECEPTORS; TETRAPEPTIDES; (RADIOLIGAND BINDING);
D O I
10.1016/0014-2999(91)90180-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We investigated the binding affinity of new tetrapeptides derived from the C-terminal sequence of CCK8 to central CCK(B) and peripheral CCK(A) receptors. Compound 1 (Boc-Trp-Met-Asp-Phe-NH2) showed high affinity for central CCK(B) receptors (K(i) 4.2 X 10(-8) M, pancreas/ cortex ratio = 283). Compounds 2 (Suc-Trp-Met-Asp-Phe-NH2) and 3 (Suc-Trp-Leu-Asp-Phe-NH2) also exhibited high affinity (K(i) 2.7 X 10(-8) M and 5.6 x 10(-8) M, respectively) but their CCK(B) selectivity was nearly 50 times higher (K(i)(ratio > 14000). Replacement of Met or Leu by other amino acids resulted in less effective tetrapeptides.
引用
收藏
页码:263 / 266
页数:4
相关论文
共 10 条
[2]  
CHANG RSL, 1989, MOL PHARMACOL, V35, P803
[3]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[4]   DESIGN OF POTENT, ORALLY EFFECTIVE, NONPEPTIDAL ANTAGONISTS OF THE PEPTIDE-HORMONE CHOLECYSTOKININ [J].
EVANS, BE ;
BOCK, MG ;
RITTLE, KE ;
DIPARDO, RM ;
WHITTER, WL ;
VEBER, DF ;
ANDERSON, PS ;
FREIDINGER, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (13) :4918-4922
[5]  
LIN CW, 1985, J PHARMACOL EXP THER, V232, P775
[6]  
LIN CW, 1989, MOL PHARMACOL, V36, P881
[7]   A NEW POTENT AND SELECTIVE NON-PEPTIDE GASTRIN ANTAGONIST AND BRAIN CHOLECYSTOKININ RECEPTOR (CCK-B) LIGAND - L-365,260 [J].
LOTTI, VJ ;
CHANG, RSL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 162 (02) :273-280
[8]  
MOODY TW, 1989, J CELL BIOL, V107, pA482
[9]   2 BRAIN CHOLECYSTOKININ RECEPTORS - IMPLICATIONS FOR BEHAVIORAL ACTIONS [J].
MORAN, TH ;
ROBINSON, PH ;
GOLDRICH, MS ;
MCHUGH, PR .
BRAIN RESEARCH, 1986, 362 (01) :175-179
[10]  
TOBLER HJ, 1983, N-S ARCH PHARMACOL, V322, P183, DOI 10.1007/BF00500763